Accurate Classification System for Patients With COVID-19 Pneumonitis
1 other identifier
observational
669
1 country
1
Brief Summary
The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2020
CompletedFirst Submitted
Initial submission to the registry
March 7, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedMarch 10, 2020
March 1, 2020
2 months
March 7, 2020
March 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
survival status
survival status as of February 24, 2020
10 December 2019 to 10 February 2020
Study Arms (2)
modeling cohort
The 445 patients were grouped in chronological order.
validating colort
The remaining 224 patients.
Eligibility Criteria
Patients with novel coronavirus pneumonia, and all cases were collected from the People's Hospital of Wuhan University.
You may qualify if:
- Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.
You may not qualify if:
- Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
- Suspected patient review refers to the negative nucleic acid test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qiong Gong, MD.
Renmin Hospital of Wuhan University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 7, 2020
First Posted
March 10, 2020
Study Start
December 10, 2019
Primary Completion
February 10, 2020
Study Completion
March 4, 2020
Last Updated
March 10, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
Not going to share for the time being.